FindTrial
Sign In

ADV/HSV-tk

BIOLOGICAL2 trials

Sponsors

Eric Bernicker, MD, The Methodist Hospital Research Institute

Conditions

Lung Squamous Cell Carcinoma Stage IVMetastatic Non-small Cell Lung CancerMetastatic Triple-negative Breast CancerMetastatic Uveal MelanomaNonsquamous Nonsmall Cell Neoplasm of Lung

Phase 2

Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma
TerminatedNCT02831933
Eric Bernicker, MDLung Squamous Cell Carcinoma Stage IV, Metastatic Uveal Melanoma, Nonsquamous Nonsmall Cell Neoplasm of Lung
Start: 2017-02-15End: 2020-11-05Updated: 2023-09-21
SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
CompletedNCT03004183
The Methodist Hospital Research InstituteMetastatic Non-small Cell Lung Cancer, Metastatic Triple-negative Breast Cancer
Start: 2017-07-01End: 2024-01-09Updated: 2024-10-15

Related Papers

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.
2023-11-104 citations
Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.
Journal of Clinical Oncology2021-05-208 citations
Abstract CT064: Trial of SBRT and in-situ gene therapy followed by nivolumab in metastatic non-small cell lung carcinoma (ENSIGN)
Cancer Research2017-07-011 citations